← Back to patent-cliff list
CAS 501-97-3
3-(4-Hydroxyphenyl)propionic acid3-(4-hydroxyphenyl)propanoic acid
Codes: (VII)828549-1-b, LAND-004, (X)819152-1-a
Application context (from source-drug indications)
Prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Diagnostic agentTLX-591 companion diagnostic (Telix Pharmaceuticals)Castration-resistant prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Hepatocellular carcinomaTLX-591 companion diagnostic (Telix Pharmaceuticals)Castration-sensitive prostate cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Bladder cancerTLX-591 companion diagnostic (Telix Pharmaceuticals)Supraventricular tachycardiaLandiolol Hydrochloride室性心律失常Landiolol HydrochlorideArrhythmiaLandiolol Hydrochloride窦性心动过速Landiolol HydrochlorideAtrial fibrillationLandiolol HydrochlorideAtrial flutterLandiolol HydrochlorideHead and neck squamous cell carcinomacRGD-ZW800-1CholangiocarcinomacRGD-ZW800-1Pancreatic cancercRGD-ZW800-1
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| TLX-591 companion diagnostic (Telix Pharmaceuticals) | Tier C — Watch / trade | - |
| Landiolol Hydrochloride | Tier C — Watch / trade | - |
| cRGD-ZW800-1 | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
3-(3-[[(Carboxymethyl)[2-[(carboxymethyl)([2-hydroxy-5-[3-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]phenyl]methyl)amino]ethyl]amino]methyl]-4-hydroxyphenyl)propanoic acid→3-(4-Hydroxyphenyl)propionic acid→2,2'-(Ethane-1,2-diyldiazanediyl)diacetic acid→3,3'-(Ethane-1,2-diylbis[[(carboxymethyl)azanediyl]methylene(4-hydroxy-3,1-phenylene)])dipropanoic acid→2,2'-[Ethane-1,2-diylbis([[5-(2-carboxyethyl)-2-oxidophenyl]methyl]azanediyl)]diacetate iron(3+)→[[2-[[[5-(2-Carboxyethyl)-2-oxidophenyl]methyl](carboxylatomethyl)amino]ethyl]([2-oxido-5-[3-oxo-3-(2,3,5,6-tetrafluorophenoxy)propyl]phenyl]methyl)amino]acetate iron(3+)
(S)-3-chloropropane-1,2-diol→2-methoxyprop-1-ene→(S)-4-(chloromethyl)-2,2-dimethyl-1,3-dioxolane→3-(4-hydroxyphenyl)propanoic acid→(S)-(2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-hydroxyphenyl)propanoate→(S)-2-(bromomethyl)oxirane→((S)-2,2-dimethyl-1,3-dioxolan-4-yl)methyl 3-(4-(((S)-oxiran-2-yl)methoxy)phenyl)propanoate→N-(2-aminoethyl)morpholine-4-carboxamide
4-Hydrazinobenzenesulfonic acid→2-Acetylpropane→Potassium 2,3,3-trimethyl-3H-indole-5-sulfonate→2,3,3-Trimethyl-3H-indole-5-sulfonic acid→3-Bromo-N,N,N-trimethylpropan-1-aminium bromide→2,3,3-Trimethyl-5-sulfo-1-[3-(trimethylazaniumyl)propyl]-3H-indol-1-ium dibromide→4-Cyclohexanone→[3-(Anilinomethylidene)-2-chlorocyclohex-1-en-1-yl]-N-phenylmethaniminium chloride→2-[2-[2-Chloro-3-[2-[3,3-dimethyl-5-sulfonato-1-[3-(trimethylazaniumyl)propyl]-1,3-dihydro-2H-indol-2-ylidene]ethylidene]cyclohex-1-en-1-yl]ethenyl]-3,3-dimethyl-1-[3-(trimethylazaniumyl)propyl]-3H-indol-1-ium-5-sulfonate sodium bromide (1/2/3)→Disodium 3-(4-oxidophenyl)propanoate→3-(4-Hydroxyphenyl)propionic acid→3-[4-[[6-[2-[3,3-dimethyl-5-sulfonato-1-[3-(trimethylazaniumyl)propyl]-1,3-dihydro-2H-indol-2-ylidene]ethylidene]-2-[2-[3,3-dimethyl-5-sulfonato-1-[3-(trimethylazaniumyl)propyl]-3H-indol-1-ium-2-yl]ethenyl]cyclohex-1-en-1-yl]oxy]phenyl]propanoate trifluoroacetic acid
Intermediates available on this site
No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.